AMLX vs. NUTX
AMLX (Amylyx Pharmaceuticals, Inc.) and NUTX (Nutex Health Inc) are both stocks. Both are in the Healthcare sector — AMLX in Biotechnology, NUTX in Health Information Services. Over the past 3 years, AMLX returned -10.96%/yr vs 30.28%/yr for NUTX. At a 0.16 correlation, their price movements are largely independent.
Performance
AMLX vs. NUTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, AMLX achieves a 34.77% return, which is significantly higher than NUTX's -8.78% return.
AMLX
- 1D
- 3.89%
- 1M
- 19.88%
- YTD
- 34.77%
- 6M
- 30.24%
- 1Y
- 222.38%
- 3Y*
- -10.96%
- 5Y*
- —
- 10Y*
- —
NUTX
- 1D
- -0.23%
- 1M
- 26.29%
- YTD
- -8.78%
- 6M
- -16.36%
- 1Y
- 31.86%
- 3Y*
- 30.28%
- 5Y*
- —
- 10Y*
- —
AMLX vs. NUTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|---|
AMLX Amylyx Pharmaceuticals, Inc. | 34.77% | 219.58% | -74.32% | -60.16% | 186.88% |
NUTX Nutex Health Inc | -8.78% | 419.47% | 17.37% | -90.53% | -81.82% |
Correlation
The correlation between AMLX and NUTX is 0.09, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.09 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (All Time) Calculated using the full available price history since Apr 4, 2022 | 0.16 |
Fundamentals
AMLX:
-$1.55
NUTX:
$19.08
AMLX:
$0.00
NUTX:
$879.95M
AMLX:
-$20.10M
NUTX:
$417.67M
AMLX:
-$150.30M
NUTX:
$275.94M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
AMLX vs. NUTX — Risk / Return Rank
AMLX
NUTX
AMLX vs. NUTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Amylyx Pharmaceuticals, Inc. (AMLX) and Nutex Health Inc (NUTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| AMLX | NUTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.99 | ||
| Sortino ratioReturn per unit of downside risk | +2.73 | ||
| Omega ratioGain probability vs. loss probability | 1.44 | 1.14 | +0.30 |
| Calmar ratioReturn relative to maximum drawdown | 7.31 | 0.59 | +6.72 |
| Martin ratioReturn relative to average drawdown | 15.68 | 1.03 | +14.65 |
Loading charts...
Drawdowns
AMLX vs. NUTX - Drawdown Comparison
The maximum AMLX drawdown since its inception was -96.04%, roughly equal to the maximum NUTX drawdown of -99.93%. Use the drawdown chart below to compare losses from any high point for AMLX and NUTX.
Loading charts...
Drawdown Indicators
| AMLX | NUTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.04% | -99.93% | +3.89% |
Max Drawdown (1Y)Largest decline over 1 year | -30.61% | -54.32% | +23.71% |
Max Drawdown (3Y)Largest decline over 3 years | -93.09% | -93.95% | +0.86% |
Current DrawdownCurrent decline from peak | -60.22% | -97.50% | +37.28% |
Average DrawdownAverage peak-to-trough decline | -59.40% | -97.18% | +37.78% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 14.25% | 31.02% | -16.77% |
Volatility
AMLX vs. NUTX - Volatility Comparison
Amylyx Pharmaceuticals, Inc. (AMLX) and Nutex Health Inc (NUTX) have volatilities of 16.44% and 16.28%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| AMLX | NUTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 16.44% | 16.28% | +0.16% |
Volatility (6M)Calculated over the trailing 6-month period | 43.21% | 62.51% | -19.30% |
Volatility (1Y)Calculated over the trailing 1-year period | 67.39% | 93.38% | -25.99% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 91.47% | 191.46% | -99.99% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 91.47% | 191.46% | -99.99% |
Dividends
AMLX vs. NUTX - Dividend Comparison
Neither AMLX nor NUTX has paid dividends to shareholders.
Financials
AMLX vs. NUTX - Financials Comparison
This section allows you to compare key financial metrics between Amylyx Pharmaceuticals, Inc. and Nutex Health Inc. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
AMLX and NUTX have a correlation of 0.09, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
AMLX has higher volatility (16.44%) compared to NUTX (16.28%). In terms of maximum drawdown, AMLX dropped -96.04% vs NUTX's -99.93%.
AMLX currently has the higher Sharpe Ratio (3.33 vs 0.34), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for AMLX and NUTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer